Showing results (331-340 of 364) with videos related to
Sort By:
Pageof 37
Japanese Journal of Clinical Oncology|August 2, 2008
Personality and colorectal cancer: the Fukuoka colorectal cancer studyJun Nagano, Suminori Kono, Kengo Toyomura, et al.Chemical Communications (Cambridge, England)|January 18, 2022
RBD conjugate vaccine with a built-in TLR1/2 agonist is highly immunogenic against SARS-CoV-2 and variants of concernShi-Hao Zhou, Ru-Yan Zhang, Hai-Wei Zhang, et al.Diabetes & Metabolism Journal|June 26, 2019
Role of MicroRNA-34a in Anti-Apoptotic Effects of Granulocyte-Colony Stimulating Factor in Diabetic CardiomyopathyIn Hwa Park, Yi Sun Song, Hyun Woo Joo, et al.BMC Cancer|June 11, 2010
Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer StudyHoirun Nisa, Suminori Kono, Guang Yin, et al.The Journal of Cell Biology|December 10, 2019
NCAM regulates temporal specification of neural progenitor cells via profilin2 during corticogenesisRui Huang, De-Juan Yuan, Shao Li, et al.Molecular Pain|March 23, 2017
Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's diseaseChen-Tao Wang, Cheng-Jie Mao, Xiao-Qi Zhang, et al.Chemistry, an Asian Journal|May 2, 2019
Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid-Dependent Immunodominant ResponseJing-Jing Du, Shi-Yao Zou, Xiang-Zhao Chen, et al.Gut|February 2, 2026
Low-frequency repetitive transcranial magnetic stimulation attenuates visceral pain in IBS with diarrhoea via inhibition of the medial prefrontal cortexRui-Xia Weng, Wei Lin, Qian Sun, et al.Journal of Medicinal Chemistry|January 10, 2023
Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV-2Dong Ding, Yu Wen, Chun-Miao Liao, et al.Acta Pharmacologica Sinica|March 9, 2021
Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cellsXuan Ni, Zhuang-Zhuang Yang, Ling-Qun Ye, et al.Pageof 37